Evis Sala

1 Patent

• US120362122024

  Enhancement of Tumor Response to Chemotherapy by Activation of the Asmase/ceramide Pathway Through Timed Administration of a Short-acting Anti-angiogenic Agent

  Memorial Sloan-kettering Cancer Center

  0 cites